The c.29T>C polymorphism of the transforming growth factor beta-1 (TGFB1) gene, bone mineral density and the occurrence of low-energy fractures in patients with inflammatory bowel disease
- PMID: 28993955
- DOI: 10.1007/s11033-017-4131-2
The c.29T>C polymorphism of the transforming growth factor beta-1 (TGFB1) gene, bone mineral density and the occurrence of low-energy fractures in patients with inflammatory bowel disease
Abstract
Gastrointestinal tract conditions are frequently associated with low bone mineral density and increased risk of fractures due to osteoporosis, the latter concerning particularly inflammatory bowel disease (IBD) patients. One of the candidate genes involved in osteoporosis is the transforming growth factor beta-1 (TGFB1) whose polymorphisms may be responsible for the development of this disease. The aim of this study was to analyse the frequency of TGFB1 polymorphic variants and determine the association between the c.29T>C TGFB1 polymorphism, and bone mineral density and fractures in IBD patients. The study subjects included 198 IBD patients [100 suffering from Crohn's disease (CD) and 98 from ulcerative colitis (UC)] and 41 healthy volunteers as a control group. Densitometric bone measurements were obtained using dual energy X-ray absorptiometry. The TGFB1 genotyping was conducted using restriction fragments length polymorphism. We conducted an analysis of genotype distribution's concordance with Hardy-Weinberg equilibrium. We found statistically significant differences in lumbar spine (L2-L4) and femoral neck BMD and T-scores between CD, UC and control subgroups. The distribution of TGFB1 polymorphic variants among CD and UC patients was concordant with Hardy-Weinberg equilibrium. There were no statistically significant differences in densitometric parameters (lumbar spine and femoral neck BMD, T-score, and Z-score) between carriers of different TGFB1 polymorphisms among IBD (CD and UC) patients nor among controls. We have found no statistically significant differences in the prevalence of low-energy fractures between groups of different TGFB1 polymorphic variant carriers. The allele dose effect, recessive effect and dominant effect analysis did not show an association between low-energy fractures and the TGFB1 polymorphisms among CD and UC patients. We have not observed an association between the c.29T>C TGFB1 polymorphic variant and the bone mineral density within the cancellous and cortical bones (L2-L4 and femoral neck, respectively), or the occurrence of fractures among the IBD patients and their family members.
Keywords: Inflammatory bowel disease; Secondary osteoporosis; TGFB1 genetic polymorphism.
Similar articles
-
Bone mineral density and the 570A>T polymorphism of the bone morphogenetic protein 2 (BMP2) gene in patients with inflammatory bowel disease: a cross-sectional study.J Physiol Pharmacol. 2017 Oct;68(5):757-764. J Physiol Pharmacol. 2017. PMID: 29375051
-
Large-scale analysis of association between polymorphisms in the transforming growth factor beta 1 gene (TGFB1) and osteoporosis: the GENOMOS study.Bone. 2008 May;42(5):969-81. doi: 10.1016/j.bone.2007.11.007. Epub 2007 Dec 3. Bone. 2008. PMID: 18284942
-
Vitamin D receptor (VDR) TaqI polymorphism, vitamin D and bone mineral density in patients with inflammatory bowel diseases.Adv Clin Exp Med. 2019 Jul;28(7):955-960. doi: 10.17219/acem/97376. Adv Clin Exp Med. 2019. PMID: 30929318
-
Associations between CD24 gene polymorphisms and inflammatory bowel disease: A meta-analysis.World J Gastroenterol. 2015 May 21;21(19):6052-9. doi: 10.3748/wjg.v21.i19.6052. World J Gastroenterol. 2015. PMID: 26019472 Free PMC article. Review.
-
Systematic review of the prevalence and development of osteoporosis or low bone mineral density and its risk factors in patients with inflammatory bowel disease.World J Gastroenterol. 2020 Sep 21;26(35):5362-5374. doi: 10.3748/wjg.v26.i35.5362. World J Gastroenterol. 2020. PMID: 32994694 Free PMC article.
Cited by
-
The genetic association between osteoprotegerin (OPG) gene polymorphisms and bone mineral density (BMD) in postmenopausal women: A meta-analysis.Medicine (Baltimore). 2018 Dec;97(51):e13507. doi: 10.1097/MD.0000000000013507. Medicine (Baltimore). 2018. PMID: 30572450 Free PMC article.
-
Differentially expressed genes and miRNAs in female osteoporosis patients.Medicine (Baltimore). 2022 Jul 15;101(28):e29856. doi: 10.1097/MD.0000000000029856. Medicine (Baltimore). 2022. PMID: 35839011 Free PMC article.
-
Bone alterations in inflammatory bowel diseases.World J Clin Cases. 2019 Aug 6;7(15):1908-1925. doi: 10.12998/wjcc.v7.i15.1908. World J Clin Cases. 2019. PMID: 31423424 Free PMC article. Review.
-
3'-UTR Polymorphisms of MTHFR and TS Associated with Osteoporotic Vertebral Compression Fracture Susceptibility in Postmenopausal Women.Int J Mol Sci. 2018 Mar 12;19(3):824. doi: 10.3390/ijms19030824. Int J Mol Sci. 2018. PMID: 29534533 Free PMC article.
-
ESR1 Gene Variants Are Predictive of Osteoporosis in Female Patients with Crohn's Disease.J Clin Med. 2019 Aug 24;8(9):1306. doi: 10.3390/jcm8091306. J Clin Med. 2019. PMID: 31450614 Free PMC article.
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous